1. A. A pharmacist in an infusion pharmacy shall adhere to the policies and procedures set forth in Regulation .06 of this chapter.

2. B. A pharmacist shall:

   1. (1) Provide infusion therapy services in accordance with:

      1. (a) Orders issued by a licensed authorized prescriber of record; and
      2. (b) Where applicable, protocols issued by a licensed authorized prescriber of record.

   2. (2) Perform and document initial and ongoing assessments of the appropriateness of infusion therapy using the following information:

      1. (a) Patient demographics including:

         1. (i) Name;
         2. (ii) Address;
         3. (iii) Telephone number;
         4. (iv) Gender; and
         5. (v) Date of birth;
      2. (b) Emergency contact information;

      3. (c) Diagnoses, including:

         1. (i) Diagnosis being treated; and
         2. (ii) Concurrent conditions, including pregnancy and lactation status if applicable;
      4. (d) Medical history;
      5. (e) Allergies;
      6. (f) If applicable, height;
      7. (g) Weight;
      8. (h) Parenteral medication orders, including length of therapy;

      9. (i) Parenteral infusion access device:

         1. (i) Location;
         2. (ii) Type; and
         3. (iii) If available, date of placement;
      10. (j) Ongoing medication profile review and reconciliation at end of therapy;
      11. (k) First dose status;

      12. (l) Caregiver information including, but not limited to:

          1. (i) Name;
          2. (ii) Address;
          3. (iii) Phone number; and
          4. (iv) Relationship to patient;
      13. (m) If applicable, contact information for other agencies or individuals involved in the patient’s home care;

      14. (n) Documented applicable medical and social factors and functional limitations which may affect infusion therapy including but not limited to:

          1. (i) Language;
          2. (ii) Sight;
          3. (iii) Hearing;
          4. (iv) History of IV drug abuse;
          5. (v) History of drug or alcohol abuse; or
          6. (vi) Other physical or mental limitations; and
      15. (o) If applicable to therapy, baseline labs;

   3. (3) Create a patient care plan specific to the patient’s:

      1. (a) Diagnosis;
      2. (b) Prescribed therapy; and
      3. (c) Concurrent conditions;
   4. (4) When compounding sterile preparations, comply with COMAR 10.34.19;
   5. (5) If sterile compounding is outsourced, comply with COMAR 10.34.04;
   6. (6) As applicable, retrieve and assess lab values and other monitoring parameters;

   7. (7) Document in the patient chart:

      1. (a) New prescription orders;
      2. (b) Changes in prescription orders;
      3. (c) Information obtained from the patient or caregiver; and

      4. (d) Other necessary information obtained from the:

         1. (i) Patient;
         2. (ii) Caregiver;
         3. (iii) Infusion nurse;
         4. (iv) Licensed authorized prescriber of record; or
         5. (v) Other sources relevant to patient care;
   8. (8) Verify prescription label accuracy;

   9. (9) Communicate as appropriate, throughout the patient’s therapy with the:

      1. (a) Licensed authorized prescriber of record or agent of the licensed authorized prescriber of record;
      2. (b) Patient’s infusion nurse;
      3. (c) Patient; and
      4. (d) Caregiver; and
   10. (10) Review therapy-specific considerations such as pain and nutrition status.

Authority: Health-Occupations Article, §12-205, Annotated Code of Maryland

Effective date: March 1, 2012 (38:23 Md. R. 1421)